PURPOSE: The ataxia telangiectasia mutated (ATM) gene mediates detection and repair of DNA damage. We investigated associations between ATM polymorphisms and severe radiation-induced pneumonitis (RP). METHODS AND MATERIALS: We genotyped 3 potentially functional single nucleotide polymorphisms (SNPs) of ATM (rs1801516 [D1853N/5557G>A], rs189037 [-111G>A] and rs228590) in 362 patients with non-small cell lung cancer (NSCLC), who received definitive (chemo)radiation therapy. The cumulative severe RP probabilities by genotypes were evaluated using the Kaplan-Meier analysis. The associations between severe RP risk and genotypes were assessed by both logistic regression analysis and Cox proportional hazard model with time to event considered. RESULTS: Of 362 patients (72.4% of non-Hispanic whites), 56 (15.5%) experienced grade ≥3 RP. Patients carrying ATM rs189037 AG/GG or rs228590 TT/CT genotypes or rs189037G/rs228590T/rs1801516G (G-T-G) haplotype had a lower risk of severe RP (rs189037: GG/AG vs AA, adjusted hazard ratio [HR] = 0.49, 95% confidence interval [CI], 0.29-0.83, P=.009; rs228590: TT/CT vs CC, HR=0.57, 95% CI, 0.33-0.97, P=.036; haplotype: G-T-G vs A-C-G, HR=0.52, 95% CI, 0.35-0.79, P=.002). Such positive findings remained in non-Hispanic whites. CONCLUSIONS: ATM polymorphisms may serve as biomarkers for susceptibility to severe RP in non-Hispanic whites. Large prospective studies are required to confirm our findings.
PURPOSE: The ataxia telangiectasia mutated (ATM) gene mediates detection and repair of DNA damage. We investigated associations between ATM polymorphisms and severe radiation-induced pneumonitis (RP). METHODS AND MATERIALS: We genotyped 3 potentially functional single nucleotide polymorphisms (SNPs) of ATM (rs1801516 [D1853N/5557G>A], rs189037 [-111G>A] and rs228590) in 362 patients with non-small cell lung cancer (NSCLC), who received definitive (chemo)radiation therapy. The cumulative severe RP probabilities by genotypes were evaluated using the Kaplan-Meier analysis. The associations between severe RP risk and genotypes were assessed by both logistic regression analysis and Cox proportional hazard model with time to event considered. RESULTS: Of 362 patients (72.4% of non-Hispanic whites), 56 (15.5%) experienced grade ≥3 RP. Patients carrying ATM rs189037 AG/GG or rs228590 TT/CT genotypes or rs189037G/rs228590T/rs1801516G (G-T-G) haplotype had a lower risk of severe RP (rs189037: GG/AG vs AA, adjusted hazard ratio [HR] = 0.49, 95% confidence interval [CI], 0.29-0.83, P=.009; rs228590: TT/CT vs CC, HR=0.57, 95% CI, 0.33-0.97, P=.036; haplotype: G-T-G vs A-C-G, HR=0.52, 95% CI, 0.35-0.79, P=.002). Such positive findings remained in non-Hispanic whites. CONCLUSIONS:ATM polymorphisms may serve as biomarkers for susceptibility to severe RP in non-Hispanic whites. Large prospective studies are required to confirm our findings.
Authors: Alice Y Ho; David P Atencio; Sheila Peters; Richard G Stock; Silvia C Formenti; Jamie A Cesaretti; Sheryl Green; Bruce Haffty; Karen Drumea; Larisa Leitzin; Abraham Kuten; David Azria; Mahmut Ozsahin; Jens Overgaard; Christian N Andreassen; Cynthia S Trop; Janelle Park; Barry S Rosenstein Journal: Int J Radiat Oncol Biol Phys Date: 2006-07-01 Impact factor: 7.038
Authors: Christian N Andreassen; Jens Overgaard; Jan Alsner; Marie Overgaard; Carsten Herskind; Jamie A Cesaretti; David P Atencio; Sheryl Green; Silvia C Formenti; Richard G Stock; Barry S Rosenstein Journal: Int J Radiat Oncol Biol Phys Date: 2005-12-09 Impact factor: 7.038
Authors: Trevor J Pugh; Mira Keyes; Lorena Barclay; Allen Delaney; Martin Krzywinski; Dallas Thomas; Karen Novik; Cindy Yang; Alexander Agranovich; Michael McKenzie; W Jim Morris; Peggy L Olive; Marco A Marra; Richard A Moore Journal: Clin Cancer Res Date: 2009-07-28 Impact factor: 12.531
Authors: Basil V Worgul; Lubomir Smilenov; David J Brenner; Anna Junk; Wei Zhou; Eric J Hall Journal: Proc Natl Acad Sci U S A Date: 2002-07-15 Impact factor: 11.205
Authors: Sofia I Vuorinen; Rachel K Okolicsanyi; Martina Gyimesi; Jacob Meyjes-Brown; Deepa Saini; Son H Pham; Lyn R Griffiths; Larisa M Haupt Journal: J Cancer Res Clin Oncol Date: 2022-09-24 Impact factor: 4.322
Authors: Dirk De Ruysscher; Jianyue Jin; Tim Lautenschlaeger; Jin-Xiong She; Zhongxing Liao; Feng-Ming Spring Kong Journal: Transl Lung Cancer Res Date: 2017-12